1174 related articles for article (PubMed ID: 32928094)
101. Mesoporous silica nanoparticles as nanocarriers.
Wu SH; Hung Y; Mou CY
Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
[TBL] [Abstract][Full Text] [Related]
102. The Bioimaging Applications of Mesoporous Silica Nanoparticles.
Pratiwi FW; Kuo CW; Wu SH; Chen YP; Mou CY; Chen P
Enzymes; 2018; 43():123-153. PubMed ID: 30244805
[TBL] [Abstract][Full Text] [Related]
103. Characterization of Drug with Good Glass-Forming Ability Loaded Mesoporous Silica Nanoparticles and Its Impact Toward in vitro and in vivo Studies.
Budiman A; Anastasya G; Handini AL; Lestari IN; Subra L; Aulifa DL
Int J Nanomedicine; 2024; 19():2199-2225. PubMed ID: 38465205
[TBL] [Abstract][Full Text] [Related]
104. Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy.
Rezaei Harandi Z; Heidari R; Reiisi S
IEEE Trans Nanobioscience; 2023 Oct; 22(4):872-880. PubMed ID: 37022888
[TBL] [Abstract][Full Text] [Related]
105. Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis.
Kuthati Y; Sung PJ; Weng CF; Mou CY; Lee CH
J Nanosci Nanotechnol; 2013 Apr; 13(4):2399-430. PubMed ID: 23763117
[TBL] [Abstract][Full Text] [Related]
106. Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins.
Tu J; Boyle AL; Friedrich H; Bomans PH; Bussmann J; Sommerdijk NA; Jiskoot W; Kros A
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32211-32219. PubMed ID: 27933855
[TBL] [Abstract][Full Text] [Related]
107. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
[TBL] [Abstract][Full Text] [Related]
108. Hydrolytic surface erosion of mesoporous silica nanoparticles for efficient intracellular delivery of cytochrome c.
Choi E; Lim DK; Kim S
J Colloid Interface Sci; 2020 Feb; 560():416-425. PubMed ID: 31679782
[TBL] [Abstract][Full Text] [Related]
109. [Progress of mesoporous silica nanoparticles in targeting drug delivery system of antitumor drug].
Zhang HM; Mo S; Liu XQ; Han FM; Wang JY; Wang ZM
Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3450-5. PubMed ID: 26978988
[TBL] [Abstract][Full Text] [Related]
110. Mesoporous silica nanoparticles in nanotechnology.
Douroumis D; Onyesom I; Maniruzzaman M; Mitchell J
Crit Rev Biotechnol; 2013 Sep; 33(3):229-45. PubMed ID: 22724458
[TBL] [Abstract][Full Text] [Related]
111. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
112. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
Sarkar S; Ekbal Kabir M; Kalita J; Manna P
Chembiochem; 2023 Apr; 24(7):e202200672. PubMed ID: 36719179
[TBL] [Abstract][Full Text] [Related]
113. pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration.
Gong S; Lang S; Wang Y; Li X; Tian A; Ma J; Ma X
Int J Nanomedicine; 2024; 19():6337-6358. PubMed ID: 38946884
[TBL] [Abstract][Full Text] [Related]
114. Mesoporous silica nanoparticles in medicine--recent advances.
Mamaeva V; Sahlgren C; Lindén M
Adv Drug Deliv Rev; 2013 May; 65(5):689-702. PubMed ID: 22921598
[TBL] [Abstract][Full Text] [Related]
115. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
116. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
117. Lubrication and drug release behaviors of mesoporous silica nanoparticles grafted with sulfobetaine-based zwitterionic polymer.
Wan L; Tan X; Sun T; Sun Y; Luo J; Zhang H
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110886. PubMed ID: 32409044
[TBL] [Abstract][Full Text] [Related]
118. Mesoporous materials used in medicine and environmental applications.
Gunduz O; Yetmez M; Sonmez M; Georgescu M; Alexandrescu L; Ficai A; Ficai D; Andronescu E
Curr Top Med Chem; 2015; 15(15):1501-15. PubMed ID: 25877095
[TBL] [Abstract][Full Text] [Related]
119. Dendrimer-like mesoporous silica nanospheres with suitable surface functionality to combat the multidrug resistance.
Xu W; Gao X; Ge P; Jiang F; Zhang X; Xie J
Int J Pharm; 2018 Dec; 553(1-2):349-362. PubMed ID: 30393166
[TBL] [Abstract][Full Text] [Related]
120. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats.
Fahmy HM; Ahmed MM; Mohamed AS; Shams-Eldin E; Abd El-Daim TM; El-Feky AS; Mustafa AB; Abd Alrahman MW; Mohammed FF; Fathy MM
BMC Pharmacol Toxicol; 2022 Sep; 23(1):71. PubMed ID: 36163187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
